Peter Hamer
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- NF-κB Signaling Pathways
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 13
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
-
- Protease and Inhibitor Mechanisms 8
- Co-authors
- Walter P. Carney (18 shared papers)Anthony J. Capobianco (2 shared papers)George Mosialos (2 shared papers)Thomas D. Gilmore (2 shared papers)Richard A. Laursen (2 shared papers)Allan Lipton (10 shared papers)Suhail M. Ali (9 shared papers)Dean B. Evans (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (4 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular and Cellular Biology (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesSwitzerlandDenmark
In The Last Decade
Peter Hamer
21 papers receiving 445 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 208
- Oncology 226
- Immunology and Allergy 38
- Immunology 77
- Molecular Biology 189
Countries citing papers authored by Peter Hamer
This map shows the geographic impact of Peter Hamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hamer more than expected).
Fields of papers citing papers by Peter Hamer
This network shows the impact of papers produced by Peter Hamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hamer. The network helps show where Peter Hamer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hamer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 97 | |
| 2 | 2005 | 81 | |
| 3 | 2007 | 40 | |
| 4 | 2008 | 39 | |
| 5 | 2006 | 33 | |
| 6 | 2010 | 31 | |
| 7 | 1991 | 26 | |
| 8 | 1986 | 24 | |
| 9 | 1981 | 19 | |
| 10 | 1990 | 18 | |
| 11 | 2009 | 16 | |
| 12 | 1999 | 13 | |
| 13 | 1991 | 4 | |
| 14 | 1986 | 4 | |
| 15 | 1991 | 3 | |
| 16 | 2004 | 2 | |
| 17 | 2005 | 2 | |
| 18 | Abstract #244: A Standardized CAIX immunohistochemistry test for use in formalin-fixed, paraffin-embedded (FF-PE) sections | 2009 | 1 |
| 19 | 2010 | 1 | |
| 20 | 2006 | 1 |
About Peter Hamer
Peter Hamer is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 22 papers that have together received 457 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Treatment and Pharmacology (3 papers), Cell Adhesion Molecules Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Cancer Research (208 citations), Oncology (226 citations), Immunology and Allergy (38 citations), Immunology (77 citations) and Molecular Biology (189 citations). Peter Hamer has collaborated with scholars based in United States, Switzerland and Denmark. Frequent co-authors include Walter P. Carney, Anthony J. Capobianco, George Mosialos, Thomas D. Gilmore, Richard A. Laursen, Allan Lipton, Suhail M. Ali, Dean B. Evans, Laurence M. Demers and Hilary A. Chaudri‐Ross. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.